You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Anti-VEGF therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Following Intensive Anti-VEGF Therapy in Wet AMD

Completed
  • Age-Related Macular Degeneration
  • Budapest, Hungary
  • +1 more
Dec 28, 2022

Macular Degeneration Trial (Zimura, Avastin, Lucentis)

Completed
  • Macular Degeneration
  • (no location specified)
Oct 4, 2022

Clinical Stage III Cutaneous Melanoma AJCC v8, Stage IV Melanoma, Unresectable Stage III Cutaneous Melanoma Trial in Boston

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +3 more
  • Boston, Massachusetts
  • +2 more
Sep 17, 2022

Neovascular Age-related Macular Degeneration Trial in United States (CLS-AX, Anti-VEGF)

Completed
  • Neovascular Age-related Macular Degeneration
  • Phoenix, Arizona
  • +10 more
Dec 1, 2022

Thyroid Eye Disease Trial in Boston (Sub-tenon injection of saline followed by a sub-tenon injection of aflibercept, Sub-tenon

Recruiting
  • Thyroid Eye Disease
  • Sub-tenon injection of saline followed by a sub-tenon injection of aflibercept
  • +2 more
  • Boston, Massachusetts
    Mass Eye and Ear
Feb 8, 2022

Recurrent Brain Tumor Trial in Houston (biological, other, radiation)

Active, not recruiting
  • Recurrent Brain Neoplasm
  • Bevacizumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 9, 2022

Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for

Recruiting
  • Hepatocellular Carcinoma Non-resectable
  • HAIC
  • +8 more
  • Quanzhou, Fujian, China
  • +1 more
Jan 26, 2023

Exudative Age Related Macular Degeneration Trial in Winston-Salem (Ranibizumab, Photodynamic laser treatment (PDT),

Not yet recruiting
  • Exudative Age Related Macular Degeneration
  • Winston-Salem, North Carolina
    Wake Forest Health Sciences
Nov 28, 2022

Combined TACE, TKI/Anti-VEGF and ICIs as Conversion Therapy for

Recruiting
  • Hepatocellular Carcinoma Non-resectable
  • TACE
  • +8 more
  • Quanzhou, Fujian, China
  • +3 more
Jan 29, 2023

Diabetic Macular Edema Trial in Houston (Dexamethasone implant, Aflibercept)

Recruiting
  • Diabetic Macular Edema
  • Houston, Texas
    Retina Consultants of Houston
Jul 19, 2021

Ovarian Cancer Trial in Houston (Pembrolizumab, Bevacizumab, Cyclophosphamide)

Not yet recruiting
  • Ovarian Cancer
  • Houston, Texas
    MD Anderson Cancer Center
Oct 9, 2023

Liver Cancer Trial in Houston (Bevacizumab, Atezolizumab, Sofosbuvir)

Not yet recruiting
  • Liver Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Feb 9, 2023

Liver Cancer Trial in Houston (Bevacizumab, Erlotinib)

Completed
Has Results
  • Liver Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Nov 3, 2022

Clear-cell Metastatic Renal Cell Carcinoma Trial in Brussel (patients with sunitinib or pazopanib)

Terminated
  • Clear-cell Metastatic Renal Cell Carcinoma
  • patients with sunitinib or pazopanib
  • Brussel, Belgium
    Cliniques universitaires Saint-Luc
Mar 18, 2021

Central Retinal Vein Occlusion With Macular Edema Trial in Peshawar (Group A)

Completed
Has Results
  • Central Retinal Vein Occlusion With Macular Edema
  • Group A
  • Peshawar, KPK, Pakistan
    Hayatabad Medical Complex
Apr 3, 2022

Metastatic Colorectal Carcinoma, Metastatic Malignant Tumor in the Liver, Stage IV Colorectal Cancer AJCC v8 Trial (biological,

Not yet recruiting
  • Metastatic Colorectal Carcinoma
  • +3 more
  • Bevacizumab
  • +11 more
  • (no location specified)
May 9, 2023

Locally Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell

Recruiting
  • Locally Advanced Lung Non-Small Cell Carcinoma
  • +9 more
  • Duarte, California
  • +4 more
Aug 17, 2022

Genetic Change Trial in Zhengzhou (Gene evolution and molecular response under Bevacizumab treatment)

Recruiting
  • Genetic Change
  • Gene evolution and molecular response under Bevacizumab treatment
  • Zhengzhou, Henan, China
    Henan Provincial People's Hospital
Aug 21, 2022

Anti-VEGF in Real-world

Recruiting
  • Neovascular Age-related Macular Edema
  • +5 more
  • Beijing, Beijing, China
    Wen-Bin Wei
Feb 2, 2022

Liver Metastases Trial in Houston (Leucovorin, 5-FLUOROURACIL, Oxaliplatin)

Recruiting
  • Liver Metastases
  • Houston, Texas
    M D Anderson Cancer Center
Apr 26, 2022

Macular Edema Due to Type 2 Diabetes Trial in Hangzhou (Anti-VEGF, subthreshold micropulse laser)

Recruiting
  • Macular Edema Due to Type 2 Diabetes Mellitus
  • Hangzhou, Zhejiang, China
    Second Affiliated Hospital, School of Medicine, Zhejiang Univers
Feb 26, 2023

Cervical Adenocarcinoma, Cervical Adenosarcoma, Cervical Adenosquamous Carcinoma Trial in United States (biological, other,

Recruiting
  • Cervical Adenocarcinoma
  • +47 more
  • Bevacizumab
  • +3 more
  • Phoenix, Arizona
  • +3 more
Dec 5, 2022

Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma Trial in United States (bevacizumab, radiation therapy)

Completed
Has Results
  • Adult Giant Cell Glioblastoma
  • +3 more
  • bevacizumab
  • radiation therapy
  • Birmingham, Alabama
  • +30 more
Dec 27, 2022

Recurrent Glioblastoma Trial in United States (Bevacizumab, Cediranib, Cediranib Maleate)

Active, not recruiting
  • Recurrent Glioblastoma
  • Bevacizumab
  • +3 more
  • La Jolla, California
  • +26 more
Jun 28, 2022

Metastatic Colorectal Carcinoma, Recurrent Colorectal Carcinoma, Refractory Colorectal Carcinoma Trial in United States (drug,

Active, not recruiting
Has Results
  • Metastatic Colorectal Carcinoma
  • +5 more
  • Phoenix, Arizona
  • +9 more
Jan 5, 2022